Medicine and Science from The BMJ
The BMJ brings you interviews with the people who are shaping medicine and science around the world.
The BMJ brings you interviews with the people who are shaping medicine and science around the world.
Episodes
4 days ago
4 days ago
38 min
This week we’re focusing on how healthcare is using AI systems. The NHS is firmly set on a course of AI integration, with NHS England committing £10 billion of taxpayer funds to the cause over the next three years. The pressure to implement AI in our hospitals is intense. But, how can healthcare leaders know what makes for a good AI adoption strategy? Victor Montori and Jon Tilburt are physicians from the US’ Mayo Clinic. They join us to lay out what they are calling the ‘five red flags’ that any organisation needs to consider in its AI rollout.
The UK is already having this conversation. The National Commission into the Regulation of AI in Healthcare released its initial report in June of this year. Among its findings was a call for a ‘lifecycle-based approach’ to regulation. To explain what this means, as well as how doctors can be equipped to ‘surveil’ AI systems as conditions evolve, we’re joined by the co-authors of a new BMJ editorial - Mark Ball from the University of Derby, and Elvira Perez Vallejos from the University of Nottingham.
And lastly, we talk about a research paper from last week that sparked off some concern. Researchers at Stanford University in California have used generative AI to design novel bacteriophage viruses. But, what have these scientists actually accomplished, and how can we put the right safeguards around the technology? Simon Clarke, associate professor in cellular microbiology at the University of Reading, explains the breakthrough and lays out its real implications.
References:
We can, but should we? Red flags for hasty, low integrity AI integration into healthcare
Regulating AI in healthcare: a moving target
Developments in AI designed viruses demonstrate why such research must be done in the open
4 days ago
38 min
Aug 14, 2026
Aug 14, 2026
34 min
Bipolar disorder affects almost 40 million people worldwide, but finding the right treatment is complex, and nearly half of patients struggle to follow their prescribed treatment plans.
In the first part of this episode, we discuss new research which aims to help patients and their doctors identify the right treatment. Michele De Prisco, psychiatrist and researcher at the Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques, joins us to discuss his team's comprehensive umbrella analysis of bipolar disorder treatment options.
Also this week, with the malaria vaccines RTS,S and R21 passing regulatory hurdles, and becoming available for populations around the world, the fight against malaria is shifting. Gillian Turner, Principal Research Associate at the Liverpool School of Tropical Medicine, explains the logistical challenges of the malaria vaccine rollout and what steps are needed next to control the disease.
Reading list:
Evidence based interventions for bipolar disorder across phases and age groups
Scaling up Malaria Vaccines in Africa
Aug 14, 2026
34 min
Aug 7, 2026
Aug 7, 2026
43 min
This week we focus on the external forces that shape medicine and healthcare.
Global health is changing, after the reduction in financing from wealthy nations, the global community are beginning to implement reforms to improve the situation. However, any change will be unsuccessful until we tackle the fundamental structures that govern outcomes, argue Daniel Bernal-Serrano and Omar Gabriel Torres Valencia from the London School of Hygiene and Tropical Medicine. They join us to explain how economic forces, wealth distribution, and market dynamics undermine health outcomes.
We also learn about the rapid rise in private equity financing of healthcare in the UK, and the dangers that poses to healthcare quality. Bernd Rechel is a researcher at the European Observatory on Health Systems and Policies, and explains how different countries are handling this drive for healthcare profit extraction.
Reading list:
Private equity involvement in UK healthcare
Reforming global health architecture requires confronting its political economy
Aug 7, 2026
43 min
Jul 31, 2026
Are doctors afraid of death?
Jul 31, 2026
Jul 31, 2026
49 min
In this week's podcast - the Sensitivity of Patient Questionnaires: If you've ever asked a patient to fill out a Patient Health Questionnaire (like the PHQ-9) to assess their mental health and wondered exactly how much of a change it can actually detect, new research just published on bmj.com sets out to answer that question. We're joined by Brett Thombs, Professor in the department of Psychiatry at McGill University
Also this week, Are Doctors Scared of Death? BMJ Careers Editor Abi Rimmer sits down in the studio with Richard Coker, Emeritus Professor of Public Health at LSHTM. Drawing from his early days as an HIV doctor during the onset of the AIDS epidemic, and later with infectious disease outbreaks in South East Asia. Professor Coker discusses the profound experiences of the end of his patients lives that shaped his new book, Timor Mortis: How We Live with Death.
Reading list:
Minimal detectable change of the Patient Health Questionnaire-9, Patient Health Questionnaire-8, and Patient Health Questionnaire-2`
Jul 31, 2026
49 min
Jul 24, 2026
Jul 24, 2026
49 min
Known for his use of devolved powers, during his tenure as Mayor of Greater Manchester, Andy Burnham now has the opportunity to bring his local blueprint to the national stage. But what does this mean for the future of health and social care?
Our panel explore the deeply rooted health inequalities tied to the social determinants of health, the disconnect between local decision-making and national infrastructure, and the urgent need to extend the ability to access social care to more of England's population.
We're joined by
Michael Marmot: Professor of Epidemiology and Public Health at University College London (UCL) and author of the landmark Marmot Review.
Sarah Woolnough: Chief Executive of the health think tank, The King's Fund.
Matt Sutton: Professor of Health Economics at the University of Manchester.
Reading List
Devolution can create new opportunities for better health
Will devolving powers to mayors close England’s health gap?
Andy Burnham’s goal of good growth could be a health-creating mission that supports environmental action
The King's Fund responds to Andy Burnham’s comments on social care
Jul 24, 2026
49 min
Jul 21, 2026
Jul 21, 2026
45 min
Discrimination in NHS Hiring: We examine the troubling success rates of Black and Asian doctors when applying for NHS jobs. Deputy news editor, Gareth Iacobucci speaks to Anthony Emmanushares his analysis on why discrimination persists in the medical workforce and what recent reports reveal.
The Ethnicity Data Gap in Research: While sex and gender are reported in 99% of trials, ethnicity is reported in only 48%. Bianca Brijnath, Professor of Health Communication in Society at La Trobe University, joins us to discuss a newly published framework aimed at standardizing the capture and reporting of ethnicity data in clinical trials.
The Evidence Revolution: We celebrate how evidence-based medicine (EBM) has set the gold standard for other areas of science. Mun-Keat Looi, The BMJ’s International News and Features Editor, speaks with Nature editor and science journalist Helen Pearson about her new book, Beyond Belief: How Evidence Shows What Really Works.
Reading List
Black and Asian doctors are up to 30 times less likely to be offered medical training posts in some specialties, data show
Measurement of ethnicity in clinical trials: Delphi survey and consensus statement
Beyond Belief: How Evidence Shows What Really Works by Helen Pearson
Jul 21, 2026
45 min
Jul 10, 2026
Jul 10, 2026
34 min
Who actually owns our health data once it is stored in the cloud? And how do we balance the global push for open medical research with the need to protect local populations from data extraction?
Kamran Abbasi sits down with Trudie Lang, Professor of Global Health Research at the University of Oxford and David Strain, Associate Professor of Cardiometabolic Health at the University of Exeter.
Together, they dive into the complex ethical and legal landscape of data sovereignty - unpacking the loopholes that could allow the US government access to NHS data, and how medical research in resource poorer settings can be extractive of data. They set out the case for data sovereignty, and how it could practically work while not stifling essential international research collaboration
Read the related articles on BMJ.com:
The CLOUD Act: NHS data must be safeguarded from US interests by David Strain
A commitment to act on data sharing by Kamran Abbasi
Data sharing must evolve towards data sovereignty by Trudie Lang
Jul 10, 2026
34 min
Jul 3, 2026
Jul 3, 2026
47 min
Two NHS maternity reviews have been published over the past few weeks. The biggest ever conducted, involving nearly 2500 families, investigated services at Nottingham university hospitals NHS trust. It was led by senior midwife, Donna Ockenden, and its findings on poor and avoidable harm to babies and mothers have reverberated throughout UK healthcare.
This was followed immediately by publication of an independent investigation into maternity and neonatal services in England, conducted by Valerie Amos, which states that the UK's poor maternity care is "on a scale that shames our society".
We speak to Kate Duhig, clinical senior lecturer at Kings College London, and Marian Knight, professor of of maternal and child population health at the University of Oxford, about why we keep having reports saying the same thing, but little action to solve the problem.
As many wealthy nations have stepped back from previous aid promises, a new force has emerged to fill the gaps: private finance. David McCoy is professor of global public health at the United Nations University, and explains why turning to investment banks, wealth funds, and private equity in the pursuit of universal health coverage might cause more problems than it solves.
Reading list:
Dangers of finance capital in healthcare
Amos maternity review: Doctors must work differently as units “no longer fit for purpose,” but report is dogged by controversy
Nottingham maternity review: 520 mothers and babies were seriously harmed on “toxic” ward, damning inquiry finds
Jul 3, 2026
47 min
Jun 26, 2026
Jun 26, 2026
38 min
Australia has been in the vanguard of legislation to try and reduce the influence of social media on children and young people - their ban for under 16s was introduced on the 10th of December 2025, to great fanfare, and a lot of interest around the world.
But how effective are these bans at keeping children away from social media?
New research just published on BMJ.com has looked at that question of efficacy - finding that children are using the most simple tactics to evade the ban.
To dicuss what that means, we're joined by two of the authors of that research Courtney Barnes and Luke Wolfenden from the University of Newcastle, Australia.
We’re also joined by Amrit Purba, from the London School of Hygiene and Tropical Medicine, and Louise Holly, from the Digital Transformations for Health Lab, in Geneva, who have written commentaries to go with that research.
Reading list
Assessing early effects of Australia’s Social Media Minimum Age Act on adolescents’ social media use
Learning from Australia’s social media age restriction policy
Early data from Australia indicate that social media companies can’t be relied on to protect children
Jun 26, 2026
38 min
Jun 22, 2026
Jun 22, 2026
48 min
The US military’s Operation “Epic Fury” highlighted the devastating cost of using artificial intelligence for rapid military planning. Thomas Adamkiewicz, associate professor at Morehouse School of Medicine, and Zulfiqar Bhutta, Robert Harding Inaugural Chair in Global Child Health at the Hospital for Sick Children, Toronto, to discuss why international humanitarian law is lagging dangerously behind technology, and why we urgently need a new era of legal frameworks to govern AI use in war.
Direct-to-consumer (DTC) advertising of prescription medicines is strictly illegal everywhere in the world except for the United States and New Zealand. Deborah Cohen, investigative journalist, joins us to explain how global social media platforms are making borders porous, allowing Hollywood celebrities and high-profile influencers to broadcast drug endorsements directly into the feeds of UK citizens.
Finally, Between 2020 and 2023, the UK government allocated £1.7 billion specifically intended for frontline doctor training. However, a deep-dive investigation has revealed that a staggering £400 million of that funding is completely unaccounted for - David Hutchison, paediatrics registrar, and Jonathan De Oliveira, GP trainee, join us to describe what they found.
Reading List
AI warfare demands a new era of humanitarian law
Bad influencers: How social media imported US-style drug advertising to the UK
“Black hole” of medical student funding
Jun 22, 2026
48 min








